Over-the-Counter Pain Medication Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Type (Acetaminophen, and Nonsteroidal Anti-inflammatory Drugs (NSAIDs)); Route of Administration (Oral, Topical, and Parenteral); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce, and Home Care), and Geography

Report Code: TIPRE00021905 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Over-the-counter (OTC) medicines are available in many different types and are good to treat many types of pain. Generally, there are two major types of OTC pain medicines such as acetaminophen (Tylenol) and nonsteroidal anti-inflammatory drugs (NSAIDs). OTC medicines can also help in reducing fevers, headaches, and other common health conditions.

MARKET DYNAMICS

The over-the-counter pain medication market growth is estimated to grow due to the growing production of generic medicines, growing approvals for OTC medicines, growing geriatric population among which incidences of pain is more, and rising product development activities in the pharmaceutical industry. The growing online distribution network by the companies are likely to serve better growth opportunities for the market in the coming future.

MARKET SCOPE

The "Over-the-Counter Pain Medication Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of over-the-counter pain medication market with detailed market segmentation by drug type, route of administration, and distribution channel. The over-the-counter pain medication market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in over-the-counter pain medication market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The over-the-counter pain medication market is segmented based on drug type, route of administration, and distribution channel. Based on drug type, the market is classified as nonsteroidal anti-inflammatory, acetaminophen, salicylates, and others. Based on route of administration, the market is classified as oral, topical, and parenteral. And based on distribution channel, the market is segmented as hospitals and retail pharmacies, online distribution, and hyper and super markets.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Over-the-counter pain medication market based on various segments. It also provides market size and forecast estimates from year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America (SCAM). The over-the-counter pain medication market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting over-the-counter pain medication market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the over-the-counter pain medication market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the over-the-counter pain medication market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from over-the-counter pain medication market are anticipated to have lucrative growth opportunities in the future with the rising demand for over-the-counter pain medication market in the global market. Below mentioned is the list of few companies engaged in the over-the-counter pain medication market.

The report also includes the profiles of key players in over-the-counter pain medication market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   GlaxoSmithKline plc.
  •   Bayer AG
  •   Pfizer Inc.
  •   Sanofi
  •   Boehringer Ingelheim GmbH
  •   Merck Co. and Inc.
  •   Johnson and Johnson Services, Inc.
  •   Takeda Pharmaceutical Company Limited.
  •   Reckitt Benckiser Group plc
  •   Teva Pharmaceutical Industries Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Over-the-Counter Pain Medication Market - By Drug Type
1.3.2 Over-the-Counter Pain Medication Market - By Route of Administration
1.3.3 Over-the-Counter Pain Medication Market - By Distribution Channel
1.3.4 Over-the-Counter Pain Medication Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. OVER-THE-COUNTER PAIN MEDICATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. OVER-THE-COUNTER PAIN MEDICATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. OVER-THE-COUNTER PAIN MEDICATION MARKET - GLOBAL MARKET ANALYSIS
6.1. OVER-THE-COUNTER PAIN MEDICATION - GLOBAL MARKET OVERVIEW
6.2. OVER-THE-COUNTER PAIN MEDICATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. OVER-THE-COUNTER PAIN MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. NONSTEROIDAL ANTI-INFLAMMATORY
7.3.1. Overview
7.3.2. Nonsteroidal Anti-inflammatory Market Forecast and Analysis
7.4. ACETAMINOPHEN
7.4.1. Overview
7.4.2. Acetaminophen Market Forecast and Analysis
7.5. SALICYLATES
7.5.1. Overview
7.5.2. Salicylates Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. OVER-THE-COUNTER PAIN MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. TOPICAL
8.4.1. Overview
8.4.2. Topical Market Forecast and Analysis
8.5. PARENTERAL
8.5.1. Overview
8.5.2. Parenteral Market Forecast and Analysis
9. OVER-THE-COUNTER PAIN MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Hospitals and Retail Pharmacies Market Forecast and Analysis
9.4. ONLINE DISTRIBUTION
9.4.1. Overview
9.4.2. Online Distribution Market Forecast and Analysis
9.5. HYPER AND SUPER MARKETS
9.5.1. Overview
9.5.2. Hyper and Super Markets Market Forecast and Analysis
10. OVER-THE-COUNTER PAIN MEDICATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Over-the-Counter Pain Medication Market Overview
10.1.2 North America Over-the-Counter Pain Medication Market Forecasts and Analysis
10.1.3 North America Over-the-Counter Pain Medication Market Forecasts and Analysis - By Drug Type
10.1.4 North America Over-the-Counter Pain Medication Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Over-the-Counter Pain Medication Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Over-the-Counter Pain Medication Market Forecasts and Analysis - By Countries
10.1.6.1 United States Over-the-Counter Pain Medication Market
10.1.6.1.1 United States Over-the-Counter Pain Medication Market by Drug Type
10.1.6.1.2 United States Over-the-Counter Pain Medication Market by Route of Administration
10.1.6.1.3 United States Over-the-Counter Pain Medication Market by Distribution Channel
10.1.6.2 Canada Over-the-Counter Pain Medication Market
10.1.6.2.1 Canada Over-the-Counter Pain Medication Market by Drug Type
10.1.6.2.2 Canada Over-the-Counter Pain Medication Market by Route of Administration
10.1.6.2.3 Canada Over-the-Counter Pain Medication Market by Distribution Channel
10.1.6.3 Mexico Over-the-Counter Pain Medication Market
10.1.6.3.1 Mexico Over-the-Counter Pain Medication Market by Drug Type
10.1.6.3.2 Mexico Over-the-Counter Pain Medication Market by Route of Administration
10.1.6.3.3 Mexico Over-the-Counter Pain Medication Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Over-the-Counter Pain Medication Market Overview
10.2.2 Europe Over-the-Counter Pain Medication Market Forecasts and Analysis
10.2.3 Europe Over-the-Counter Pain Medication Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Over-the-Counter Pain Medication Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Over-the-Counter Pain Medication Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Over-the-Counter Pain Medication Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Over-the-Counter Pain Medication Market
10.2.6.1.1 Germany Over-the-Counter Pain Medication Market by Drug Type
10.2.6.1.2 Germany Over-the-Counter Pain Medication Market by Route of Administration
10.2.6.1.3 Germany Over-the-Counter Pain Medication Market by Distribution Channel
10.2.6.2 France Over-the-Counter Pain Medication Market
10.2.6.2.1 France Over-the-Counter Pain Medication Market by Drug Type
10.2.6.2.2 France Over-the-Counter Pain Medication Market by Route of Administration
10.2.6.2.3 France Over-the-Counter Pain Medication Market by Distribution Channel
10.2.6.3 Italy Over-the-Counter Pain Medication Market
10.2.6.3.1 Italy Over-the-Counter Pain Medication Market by Drug Type
10.2.6.3.2 Italy Over-the-Counter Pain Medication Market by Route of Administration
10.2.6.3.3 Italy Over-the-Counter Pain Medication Market by Distribution Channel
10.2.6.4 Spain Over-the-Counter Pain Medication Market
10.2.6.4.1 Spain Over-the-Counter Pain Medication Market by Drug Type
10.2.6.4.2 Spain Over-the-Counter Pain Medication Market by Route of Administration
10.2.6.4.3 Spain Over-the-Counter Pain Medication Market by Distribution Channel
10.2.6.5 United Kingdom Over-the-Counter Pain Medication Market
10.2.6.5.1 United Kingdom Over-the-Counter Pain Medication Market by Drug Type
10.2.6.5.2 United Kingdom Over-the-Counter Pain Medication Market by Route of Administration
10.2.6.5.3 United Kingdom Over-the-Counter Pain Medication Market by Distribution Channel
10.2.6.6 Rest of Europe Over-the-Counter Pain Medication Market
10.2.6.6.1 Rest of Europe Over-the-Counter Pain Medication Market by Drug Type
10.2.6.6.2 Rest of Europe Over-the-Counter Pain Medication Market by Route of Administration
10.2.6.6.3 Rest of Europe Over-the-Counter Pain Medication Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Over-the-Counter Pain Medication Market Overview
10.3.2 Asia-Pacific Over-the-Counter Pain Medication Market Forecasts and Analysis
10.3.3 Asia-Pacific Over-the-Counter Pain Medication Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Over-the-Counter Pain Medication Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Over-the-Counter Pain Medication Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Over-the-Counter Pain Medication Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Over-the-Counter Pain Medication Market
10.3.6.1.1 Australia Over-the-Counter Pain Medication Market by Drug Type
10.3.6.1.2 Australia Over-the-Counter Pain Medication Market by Route of Administration
10.3.6.1.3 Australia Over-the-Counter Pain Medication Market by Distribution Channel
10.3.6.2 China Over-the-Counter Pain Medication Market
10.3.6.2.1 China Over-the-Counter Pain Medication Market by Drug Type
10.3.6.2.2 China Over-the-Counter Pain Medication Market by Route of Administration
10.3.6.2.3 China Over-the-Counter Pain Medication Market by Distribution Channel
10.3.6.3 India Over-the-Counter Pain Medication Market
10.3.6.3.1 India Over-the-Counter Pain Medication Market by Drug Type
10.3.6.3.2 India Over-the-Counter Pain Medication Market by Route of Administration
10.3.6.3.3 India Over-the-Counter Pain Medication Market by Distribution Channel
10.3.6.4 Japan Over-the-Counter Pain Medication Market
10.3.6.4.1 Japan Over-the-Counter Pain Medication Market by Drug Type
10.3.6.4.2 Japan Over-the-Counter Pain Medication Market by Route of Administration
10.3.6.4.3 Japan Over-the-Counter Pain Medication Market by Distribution Channel
10.3.6.5 South Korea Over-the-Counter Pain Medication Market
10.3.6.5.1 South Korea Over-the-Counter Pain Medication Market by Drug Type
10.3.6.5.2 South Korea Over-the-Counter Pain Medication Market by Route of Administration
10.3.6.5.3 South Korea Over-the-Counter Pain Medication Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Over-the-Counter Pain Medication Market
10.3.6.6.1 Rest of Asia-Pacific Over-the-Counter Pain Medication Market by Drug Type
10.3.6.6.2 Rest of Asia-Pacific Over-the-Counter Pain Medication Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Over-the-Counter Pain Medication Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Over-the-Counter Pain Medication Market Overview
10.4.2 Middle East and Africa Over-the-Counter Pain Medication Market Forecasts and Analysis
10.4.3 Middle East and Africa Over-the-Counter Pain Medication Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Over-the-Counter Pain Medication Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Over-the-Counter Pain Medication Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Over-the-Counter Pain Medication Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Over-the-Counter Pain Medication Market
10.4.6.1.1 South Africa Over-the-Counter Pain Medication Market by Drug Type
10.4.6.1.2 South Africa Over-the-Counter Pain Medication Market by Route of Administration
10.4.6.1.3 South Africa Over-the-Counter Pain Medication Market by Distribution Channel
10.4.6.2 Saudi Arabia Over-the-Counter Pain Medication Market
10.4.6.2.1 Saudi Arabia Over-the-Counter Pain Medication Market by Drug Type
10.4.6.2.2 Saudi Arabia Over-the-Counter Pain Medication Market by Route of Administration
10.4.6.2.3 Saudi Arabia Over-the-Counter Pain Medication Market by Distribution Channel
10.4.6.3 U.A.E Over-the-Counter Pain Medication Market
10.4.6.3.1 U.A.E Over-the-Counter Pain Medication Market by Drug Type
10.4.6.3.2 U.A.E Over-the-Counter Pain Medication Market by Route of Administration
10.4.6.3.3 U.A.E Over-the-Counter Pain Medication Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Over-the-Counter Pain Medication Market
10.4.6.4.1 Rest of Middle East and Africa Over-the-Counter Pain Medication Market by Drug Type
10.4.6.4.2 Rest of Middle East and Africa Over-the-Counter Pain Medication Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Over-the-Counter Pain Medication Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Over-the-Counter Pain Medication Market Overview
10.5.2 South and Central America Over-the-Counter Pain Medication Market Forecasts and Analysis
10.5.3 South and Central America Over-the-Counter Pain Medication Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Over-the-Counter Pain Medication Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Over-the-Counter Pain Medication Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Over-the-Counter Pain Medication Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Over-the-Counter Pain Medication Market
10.5.6.1.1 Brazil Over-the-Counter Pain Medication Market by Drug Type
10.5.6.1.2 Brazil Over-the-Counter Pain Medication Market by Route of Administration
10.5.6.1.3 Brazil Over-the-Counter Pain Medication Market by Distribution Channel
10.5.6.2 Argentina Over-the-Counter Pain Medication Market
10.5.6.2.1 Argentina Over-the-Counter Pain Medication Market by Drug Type
10.5.6.2.2 Argentina Over-the-Counter Pain Medication Market by Route of Administration
10.5.6.2.3 Argentina Over-the-Counter Pain Medication Market by Distribution Channel
10.5.6.3 Rest of South and Central America Over-the-Counter Pain Medication Market
10.5.6.3.1 Rest of South and Central America Over-the-Counter Pain Medication Market by Drug Type
10.5.6.3.2 Rest of South and Central America Over-the-Counter Pain Medication Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Over-the-Counter Pain Medication Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL OVER-THE-COUNTER PAIN MEDICATION MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. OVER-THE-COUNTER PAIN MEDICATION MARKET, KEY COMPANY PROFILES
13.1. GLAXOSMITHKLINE PLC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BAYER AG
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. PFIZER INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SANOFI
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BOEHRINGER INGELHEIM GMBH
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MERCK CO. AND INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JOHNSON AND JOHNSON SERVICES, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. TAKEDA PHARMACEUTICAL COMPANY LIMITED.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. RECKITT BENCKISER GROUP PLC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. GlaxoSmithKline plc.
2. Bayer AG
3. Pfizer Inc.
4. Sanofi
5. Boehringer Ingelheim GmbH
6. Merck Co. and Inc.
7. Johnson and Johnson Services, Inc.
8. Takeda Pharmaceutical Company Limited.
9. Reckitt Benckiser Group plc
10. Teva Pharmaceutical Industries Ltd.
11. Novartis AG
12. Mylan N.V
13. Abbott
14. AstraZeneca
15. Sun Pharmaceutical Industries Limited
TIPRE00021905
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking